Compare OLPX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLPX | OPK |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 921.2M |
| IPO Year | 2021 | 2011 |
| Metric | OLPX | OPK |
|---|---|---|
| Price | $2.03 | $1.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $1.70 | ★ $2.03 |
| AVG Volume (30 Days) | ★ 6.3M | 2.5M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $422,960,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $2.95 | N/A |
| Revenue Next Year | $3.39 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.07 | N/A |
| 52 Week Low | $0.99 | $1.10 |
| 52 Week High | $2.04 | $1.60 |
| Indicator | OLPX | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 72.62 | 47.51 |
| Support Level | $1.21 | $1.12 |
| Resistance Level | $2.04 | $1.27 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 98.05 | 48.00 |
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.